NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
2021-10-22 $174.23 $174.42 $173.50 $173.95 196 871
2021-10-21 $174.00 $174.35 $173.10 $173.75 633 929
2021-10-20 $173.77 $174.25 $172.25 $172.51 499 975
2021-10-19 $173.04 $174.30 $173.04 $173.74 363 155
2021-10-18 $173.25 $174.40 $172.85 $173.00 611 183
2021-10-15 $172.93 $173.55 $171.91 $172.94 408 525
2021-10-14 $173.75 $174.86 $172.02 $172.08 1 123 567
2021-10-13 $173.75 $174.30 $172.23 $172.59 1 074 534
2021-10-12 $175.34 $179.49 $173.28 $173.78 2 481 438
2021-10-11 $175.10 $175.89 $174.49 $174.99 861 536
2021-10-08 $175.80 $176.19 $174.81 $175.00 1 270 145
2021-10-07 $175.87 $176.50 $175.03 $175.33 2 167 870
2021-10-06 $176.62 $176.97 $175.27 $175.29 1 100 895
2021-10-05 $174.99 $177.20 $174.24 $177.13 2 124 818
2021-10-04 $173.63 $175.23 $173.21 $174.68 1 573 571
2021-10-01 $172.50 $175.07 $172.27 $174.35 2 789 958
2021-09-30 $175.09 $175.60 $171.75 $172.10 14 686 979
2021-09-29 $183.00 $189.99 $175.25 $175.36 4 039 499
2021-09-28 $179.49 $187.70 $178.60 $182.78 2 107 844
2021-09-27 $173.00 $182.44 $173.00 $178.87 1 889 566
2021-09-24 $158.94 $174.24 $158.52 $167.65 1 231 013
2021-09-23 $154.69 $161.35 $154.57 $159.84 767 907
2021-09-22 $153.36 $154.72 $149.33 $154.44 371 514
2021-09-21 $140.46 $153.86 $139.76 $153.29 1 017 814
2021-09-20 $135.94 $140.06 $134.99 $139.55 440 613
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT